In Vivo efficacy of alpha-galactosidase as possible promise for prolonged durability of bioprosthetic heart valve using alpha1,3-galactosyltransferase knockout mouse

Tissue Engineering - Part A

Volumn 19, Issue 21-22, 2013, Pages 2339-2348

  Lim, Hong Gook ^a   Choi, Sun Young ^b   Yoon, Eun Jung ^b   Kim, Soo Hwan ^b   Kim, Yong Jin ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BIOMINERALIZATION; BONE; CALCIUM; DURABILITY; EPITOPES; HISTOLOGY; MAMMALS;

ALPHA-GALACTOSIDASE; ANTICALCIFICATION; BIOPROSTHETIC HEART VALVES; BOVINE PERICARDIUM; CALCIUM CONTENT; DECELLULARIZATION; GLUTARALDEHYDES; IMMUNE RESPONSE;

TISSUE;

ALPHA GALACTOSIDASE; CALCIUM; EPITOPE; GALACTOSYLTRANSFERASE; GENIPIN; GLUTARALDEHYDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CALCIFICATION; CATTLE; CONFERENCE PAPER; CONTROLLED STUDY; HEART VALVE BIOPROSTHESIS; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; PERICARDIUM; PRIORITY JOURNAL;

BOVINAE; MUS; ORYCTOLAGUS CUNICULUS;

ALPHA-GALACTOSIDASE; ANIMALS; BIOPROSTHESIS; CALCIUM; CATTLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GALACTOSYLTRANSFERASES; HEART VALVES; IRIDOIDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERICARDIUM;

EID: 84887116491     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2013.0062     Document Type: Conference Paper

References (33)

1. Lee, C., Ahn, H., Kim, S.H., Choi, S.Y., and Kim, Y.J. Immune response to bovine pericardium implanted into a1,3-galactosyltransferase knockout mice: Feasibility as an animal model for testing efficacy of anticalcification treatments of xenografts. Eur J Cardiothorac Surg 42, 164, 2012
2. Choi, S.Y., Jeong, H.J., Lim, H.G., Park, S.S., Kim, S.H., and Kim, Y.J. Elimination of a-gal xenoreactive epitope: A-galactosidase treatment of porcine heart valves. J Heart Valve Dis 21, 387, 2012
3. Lim, H.G., Kim, S.H., Choi, S.Y., and Kim, Y.J. Anticalcification effects of decellularization, solvent, and detoxification treatment for genipin and glutaraldehyde fixation of bovine pericardium. Eur J Cardiothorac Surg 41, 383, 2012
4. Nam, J., Choi, S.Y., Sung, S.C., Lim, H.G., Park, S.S., Kim, S.H., et al. Changes of the structural and biomechanical properties of the bovine pericardium after the removal of a-Gal epitopes by decellularization and a-galactosidase treatment. Korean J Thorac Cardiovasc Surg 45, 380, 2012
5. Min, B.J., Kim, Y.J., Choi, J.W., Choi, S.Y., Kim, S.H., and Lim, H.G. Histologic characteristics and mechanical properties of bovine pericardium treated with decellularization and a-galactosidase: A comparative study. Korean J Thorac Cardiovasc Surg 45, 368, 2012
6. Lee, C., Kim, S.H., Choi, S.H., and Kim, Y.J. Highconcentration glutaraldehyde fixation of bovine pericardium in organic solvent and post-fixation glycine treatment: In vitro material assessment and in vivo anticalcification effect. Eur J Cardiothorac Surg 39, 381, 2011
7. Park, C.S., Park, S.S., Choi, S.Y., Yoon, S.H., Kim, W.H., and Kim, Y.J. Anti alpha-gal immune response following porcine bioprosthesis implantation in children. J Heart Valve Dis 19, 124, 2010
8. Park, S.S., Kim, W.H., Choi, S.Y., and Kim, Y.J. Removal of alpha-Gal epitopes from porcine aortic valve and pericardium using recombinant human alpha Galactosidase A. J Korean Med Sci 24, 1126, 2009
9. Gabbay, S., Kadam, P., Factor, S., and Cheung, T.K. Do heart valve bioprostheses degenerate for metabolic or mechanical reasons? J Thorac Cardiovasc Surg 95, 208, 1988
10. Konakci, K.Z., Bohle, B., Blumer,R.,Hoetzenecker,W.,Roth,G., Moser, B., et al. Alpha-GAL on bioprostheses: Xenograft immune response in cardiac surgery. Eur J Clin Invest 35, 17, 2005
11. Courtman, D.W., Pereira, C.A., Kashef, V., McComb, D., Lee, J.M., and Wilson, G.J. Development of a pericardial acellular matrix biomaterial: Biochemical and mechanical effects of cell extraction. J Biomed Mater Res 28, 655, 1994
12. Bloch, O., Golde, P., Dohmen, P.M., Posner, S., Konertz, W., and Erdbrügger, W. Immune response in patients receiving a bioprosthetic heart valve: Lack of response with decellularized valves. Tissue Eng Part A. 17, 2399, 2011
13. LaVecchio, J.A., Dunne, A.D., and Edge, A.S.B. Enzymatic removal of alphagalactosyl epitopes from porcine endothelial cells diminishes the cytotoxic effect of natural antibodies. Transplantation 60, 841, 1995
14. Stone, K.R., Ayala, G., Goldstein, J., Hurst, R., Walgenbach, A., and Galili, U. Porcine cartilage transplants in the cynomolgus monkey: III Transplantation of a-galactosidase treated porcine cartilage. Transplantation 65, 1577, 1998
15. Luo, Y., Wen, J., Luo, C., Cummings, R.D., and Cooper, D.K. Pig xenogeneic antigen modification with green coffee bean alpha-galactosidase. Xenotransplantation 6, 238, 1999
16. Thall, A.D., Malý , P., and Lowe, J.B. Oocyte Gal alpha 1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J Biol Chem 270, 21437, 1995
17. Tearle, R.G., Tange, M.J., Zannettino, Z.L., Katerelos, M., Shinkel, T.A., Van, Denderen, B.J., et al. The alpha-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantation. Transplantation 61, 13, 1996
18. Pearse,M.J., Cowan, P.J., Shinkel, T.A., Chen,C.G., and d'Apice, A.J. Anti-xenograft immune responses in alpha 1,3-galactosyltransferase knock-out mice. Subcell Biochem 32, 281, 1999
19. Kheir, E., Stapleton, T., Shaw, D., Jin, Z., Fisher, J., and Ingham, E. Development and characterization of an acellular porcine cartilage bone matrix for use in tissue engineering. J Biomed Mater Res A. 99, 283, 2011
20. McKenzie, I.F., Li, Y.Q., Patton, K., Thall, A.D., and Sandrin, M.S. A murine model of antibody-mediated hyperacute rejection by galatose-A(1,3) galactose antibodies in Gal o/o mice. Transplantation 66, 754, 1998
21. Steitz, S.A., Speer, M.Y., McKee, M.D., Liaw, L., Almeida, M., Yang, H., et al. Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 161, 2035, 2002
22. Manji, R.A., Zhu, L.F., Nijjar, N.K., Rayner, D.C., Korbutt, G.S., Churchill, T.A., et al. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation 114, 318, 2006
23. Schoen, F.J., and Levy, R.J. Calcification of tissue heart valve substitutes: Progress toward understanding and prevention. Ann Thorac Surg 79, 1072, 2005
24. Chang, Y., Tsai, C.C., Liang, H.C., and Sung, H.W. In vivo evaluation of cellular and acellular bovine pericardia fixed with a naturally occurring crosslinking agent (genipin). Biomaterials 23, 2447, 2002
25. Chang, Y., Hsu, C.K., Wei, H.J., Chen, S.C., Liang, H.C., Lai, P.H., et al. Cell-free xenogenic vascular grafts fixed with glutaraldehyde or genipin: In vitro and in vivo studies. J Biotechnol 120, 207, 2005
26. Galili, U., LaTemple, D.C., Walgenbach, A.W., and Stone, K.R. Porcine and bovine cartilage transplants in cynomolgus monkey: II. Changes in anti-Gal response during chronic rejection. Transplantation 63, 646, 1997
27. Lin, S.S., Kooyman, D.L., Daniels, L.J., Daggett, C.W., Parker, W., Lawson, J.H., et al. The role of natural anti-Gala1-3Gal antibodies in hyperacute rejection of pig-To-baboon cardiac xenotransplants. Transpl Immunol 5, 212, 1997
28. Stone, K.R., Walgenbach, A.W., Abrams, J.T., Nelson, J., Gillett, N., and Galili, U. Porcine and bovine cartilage transplants in cynomolgus monkey: I. A model for chronic xenograft rejection. Transplantation 63, 640, 1997
29. Phelps, C.J., Koike, C., Vaught, T.D., Boone, J., Wells, K.D., Chen, S.H., et al. Production of a1,3-galactosyltransferasedeficient pigs. Science 299, 411, 2003
30. Schussler, O., Shen, M., Shen, L., Carpentier, S.M., Kaveri, S., and Carpentier, A. Effect of human immunoglobulins on the immunogenicity of porcine bioprostheses. Ann Thorac Surg 71, S396, 2001
31. Dai, Y., Vaught, T.D., Boone, J., Chen, S.H., Phelps, C.J., Ball, S., et al. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 20, 251, 2002
32. Galili, U., Mandrell, R.E., Hamedeh, R.M., Shohet, S.B., and Griffiths, J.M. Interaction between natural anti-[alpha]-galactosyl immunoglobulin G and bacterial of the human flora. Immun Infect 56, 1730, 1988
33. Raeder, R.H., Badylak, S.F., Sheehan, C., Kallakury, B., and Metzger, D.W. Natural anti-galactose a1,3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenografts. Transpl Immunol 10, 15, 2002